| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |